Treace James T. - 10 May 2024 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role: Director
Signature: /s/ Lisa O. Taylor as Attorney in Fact for James Treace
Issuer symbol: TMCI
Transactions as of: 10 May 2024
Net transactions value: +$1,034,004
Form type: 4
Filing time: 13 May 2024, 19:47:43 UTC
Previous filing: 02 May 2023
Next filing: 29 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMCI	Common Stock	Purchase	$376,023	+83,000	+10%	$4.53	894,441	10 May 2024	Direct	F1
transaction	TMCI	Common Stock	Purchase	$657,981	+145,000	+16%	$4.54	1,039,441	13 May 2024	Direct	F2
holding	TMCI	Common Stock						556,183	10 May 2024	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3300 to $4.7600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3800 to $4.6400 0inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3300 to $4.7600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3800 to $4.6400 0inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.